Answers are grounded in this paper and cite their sources.
This review summarizes current Russian and international guidelines and recent data on the efficacy and safety of new oral anticoagulants for preventing thromboembolic events in patients with atrial fibrillation.
Recent data and perspectives of antithrombotic therapy in patients with atrial fibrillation (AF) are highlighted. The main statements of current Russian and international guidelines about thromboembolic events prevention in AF patients are presented. Special attention paid to new agents for oral anticoagulation therapy , last information about their efficacy , safety and potential of application.
No takes yet. Share an insight, caveat, or question.
Dovgalevskiy et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: